SOAT1 and rheumatoid arthritis: Even though it needs to be confirmed in further studies if the baseline JAK-STAT signaling profile has prognostic value for tofacitinib treatment responses, this study significantly adds to our understanding about the mechanisms of tofacitinib function in RA patients receiving this treatment.